Literature DB >> 3024907

Biochemical markers in sarcoidosis.

O B Selroos.   

Abstract

The clinical course of sarcoidosis is varying and unpredictable. Once the diagnosis has been made, the clinician needs simple tests to detect and predict remission or progression, to determine whether treatment is effective or not, and to assess the clinical activity of the disease. Sarcoidosis is a multisystem disease, but the lungs are almost always involved. Traditionally, the clinical management has therefore included chest X-rays and lung function studies. Extrapulmonary lesions have been followed in different ways. Sensitive and reproducible biochemical tests would be helpful in evaluating the clinical course of patients with sarcoidosis, if they measure functions related to the granulomatous inflammation. This review will deal with measurements of serum and urinary calcium, and 1,25-dihydroxyvitamin D. The usefulness of single and serial determinations of lysozyme, angiotensin converting enzyme, beta 2-microglobulin, collagenase, carboxypeptidase and glucuronidase in serum, bronchoalveolar lavage fluid, and other biological fluids will be discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3024907     DOI: 10.3109/10408368609110273

Source DB:  PubMed          Journal:  Crit Rev Clin Lab Sci        ISSN: 1040-8363            Impact factor:   6.250


  7 in total

1.  [B symptoms, lymphadenopathy and signs of systemic disease in a 21-year-old female].

Authors:  J Mühlhausen; G A Müller; H Eiffert; G Wulf; K Holke; M Koziolek
Journal:  Internist (Berl)       Date:  2012-07       Impact factor: 0.743

2.  Identification of apolipoprotein A-I in BALF as a biomarker of sarcoidosis.

Authors:  Yoshihisa Nukui; Yasunari Miyazaki; Kozo Suhara; Tsukasa Okamoto; Haruhiko Furusawa; Naohiko Inase
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

3.  Sarcoidois: is it only a mimicker of primary rheumatic disease? A single center experience.

Authors:  Senol Kobak; Fidan Sever; Oya Nermin Sivrikoz; Mehmet Orman
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-02       Impact factor: 5.346

4.  Subcutaneous sarcoidosis: a clinical analysis of nine patients.

Authors:  Masaru Ando; Eishi Miyazaki; Yutaka Hatano; Suehiro Nishio; Chihiro Torigoe; Mari Yamasue; Yutaka Mukai; Shin-Ichi Nureki; Jun-Ichi Kadota
Journal:  Clin Rheumatol       Date:  2016-07-23       Impact factor: 2.980

5.  Activation of peripheral blood mononuclear cells in bronchoalveolar lavage fluid from patients with sarcoidosis: visualisation of single cell activation products.

Authors:  P Pantelidis; A M Southcott; A D Cambrey; G J Laurent; R M du Bois
Journal:  Thorax       Date:  1994-11       Impact factor: 9.139

6.  Serum ACE Level in Sarcoidosis Patients with Typical and Atypical HRCT Manifestation.

Authors:  Shahram Kahkouee; Katayoon Samadi; Ali Alai; Atefeh Abedini; Lida Rezaiian
Journal:  Pol J Radiol       Date:  2016-09-23

7.  The relationship between erythema nodosum and prognosis in systemic sarcoidosis: a retrospective cohort study.

Authors:  Elif Afacan Yıldırım; Perihan Aladağ Öztürk; Esra Adışen; Nurdan Köktürk
Journal:  An Bras Dermatol       Date:  2022-07-07       Impact factor: 2.113

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.